Publications by Marianne Nordlund Broughton
19 publications found
Original articles
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
ESC Heart Fail, 5 (6), 1052-1059
DOI 10.1002/ehf2.12312, PubMed 30145817
Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
Tumour Biol, 39 (6), 1010428317707436
DOI 10.1177/1010428317707436, PubMed 28653892
To elute or not to elute in immunocapture bottom-up LC-MS
J Chromatogr B Analyt Technol Biomed Life Sci, 1055-1056, 51-60
DOI 10.1016/j.jchromb.2017.03.044, PubMed 28445847
Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies
Tumour Biol, 37 (6), 7729-39
DOI 10.1007/s13277-015-4597-2, PubMed 26695140
Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapy
BJU Int, 115 (5), 829-38
DOI 10.1111/bju.12886, PubMed 25130393
Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS
Anal Chem, 86 (14), 6983-92
DOI 10.1021/ac500986t, PubMed 24945626
Determining ProGRP and isoforms in lung and thyroid cancer patient samples: comparing an MS method with a routine clinical immunoassay
Anal Bioanal Chem, 406 (11), 2733-8
DOI 10.1007/s00216-014-7634-x, PubMed 24518900
Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum
J Chromatogr B Analyt Technol Biomed Life Sci, 929, 125-32
DOI 10.1016/j.jchromb.2013.04.010, PubMed 23669612
Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms
J Proteome Res, 12 (1), 412-20
DOI 10.1021/pr300751j, PubMed 23190087
Characteristics and clinical validity of two immunoassays for ProGRP
Tumour Biol, 33 (4), 1105-13
DOI 10.1007/s13277-012-0351-1, PubMed 22399443
Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo
Endocrinology, 153 (3), 1082-92
DOI 10.1210/en.2011-1875, PubMed 22202166
Formulation of immunoassay calibrators in pasteurized albumin can significantly enhance their durability
J Immunol Methods, 353 (1-2), 145-7
DOI 10.1016/j.jim.2009.12.001, PubMed 20006616
Immuno-capture as ultimate sample cleanup in LC-MS/MS determination of the early stage biomarker ProGRP
J Sep Sci, 32 (17), 2937-43
DOI 10.1002/jssc.200900233, PubMed 19642102
Studies on multiple forms of proGRP in serum from small cell lung cancer patients
Tumour Biol, 30 (5-6), 265-75
DOI 10.1159/000258135, PubMed 19907206
Absolute ProGRP quantification in a clinical relevant concentration range using LC-MS/MS and a comprehensive internal standard
J Chromatogr B Analyt Technol Biomed Life Sci, 877 (13), 1359-65
DOI 10.1016/j.jchromb.2008.12.023, PubMed 19124278
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide
Clin Chem, 54 (5), 919-22
DOI 10.1373/clinchem.2007.101436, PubMed 18443179
Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
Tumour Biol, 29 (3), 204-10
DOI 10.1159/000148188, PubMed 18667845
Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP
Tumour Biol, 28 (2), 100-10
DOI 10.1159/000099335, PubMed 17287611
Theses
Development, characterization and analytical use of monoclonal antibodies against proGRP with relevance to small cell lung cancer
In Series of dissertations submitted to the Faculty of Mathematics and Natural Sciences, University of Oslo, The Faculty, Oslo, nr. 844, 1 b. (flere pag.)
BIBSYS 092473555